BreatheAmerica
BreatheAmerica operates multi-specialty outpatient clinics in Louisiana, New Mexico, and Texas that treat airway and allergic conditions—allergies, asthma, sinusitis, COPD, and sleep disorders—using its integrated 'One Airway, One Disease' clinical model, reimbursed primarily through major commercial and government insurance plans.
- Company typePrivate
- Founded2006
- HeadquartersNashville, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What BreatheAmerica does
BreatheAmerica is a privately held, multi-specialty healthcare provider operating outpatient clinics that treat airway and allergic conditions under a proprietary 'One Airway, One Disease' clinical methodology. The platform combines allergy/immunology, pulmonology (asthma/COPD), otolaryngology (sinus/ENT), and sleep medicine within single clinic locations, supported by an in-house diagnostic suite that includes low-dose CT imaging, nasal endoscopy, spirometry, ImmunoCap blood testing, and skin-prick/intradermal/patch testing. Treatment offerings extend from avoidance education and medications to allergen immunotherapy (both traditional shots and sublingual tablets), balloon sinuplasty, and Propel steroid-releasing sinus implants; the company also runs a Clinical Research program providing trial access across its condition areas.
The company operates physical clinics in Shreveport and Bossier City, Louisiana; Albuquerque and Santa Fe, New Mexico; and El Paso, Texas, with a corporate/home office in Franklin, Tennessee. A separate Precision Healthcare (DBA Precision Healthcare Infusion) subsidiary provides ambulatory infusion, specialty pharmacy, home infusion, and heart failure programs across Tennessee, Arkansas, New Mexico, Texas, and Oklahoma. Patients access care through direct appointment scheduling (online and phone), a digital physician-referral portal, community events, and earned-media appearances, generating revenue predominantly through insurance reimbursement from major payers (BCBS, Medicare, United Healthcare, Aetna, Cigna, Humana, Tricare, and regional Medicaid plans) with self-pay as a secondary channel. Capital history includes equity rounds in 2011 ($22M), 2012 ($5M), and 2013 ($2.8M), each anchored by Essex Woodlands Healthcare Partners.
BreatheAmerica firmographics
Firmographics- Name
- BreatheAmerica
- Legal name
- BreatheAmerica
- Website
- https://breatheamerica.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- BreatheAmerica operates multi-specialty outpatient clinics in Louisiana, New Mexico, and Texas that treat airway and allergic conditions—allergies, asthma, sinusitis, COPD, and sleep disorders—using its integrated 'One Airway, One Disease' clinical model, reimbursed primarily through major commercial and government insurance plans.
- Ownership category
- akta.pro rank
Where BreatheAmerica is headquartered
LocationHeadquarters
- HQ city
- Nashville
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
BreatheAmerica business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Healthcare Services: BreatheAmerica operates outpatient clinics providing diagnosis and treatment for allergies, asthma, sinusitis, COPD, and sleep disorders. Revenue is generated through insurance reimbursement (accepting most major insurance plans including BCBS, Medicare, United HealthCare, Aetna, Cigna, Humana, Tricare, and Medicaid plans) and direct patient payments for services not covered by insurance.
- Precision Infusion Services: Ambulatory infusion centers providing IV medication administration for infections and immunologic disorders. Services include specialty pharmacy, home infusion, and heart failure program. Revenue generated through insurance reimbursement and direct payments at multiple Tennessee, Arkansas, New Mexico, Texas, and Oklahoma locations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Per visit | Insurance-based healthcare services |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
BreatheAmerica product offering
Product offeringCore offering
BreatheAmerica operates outpatient specialty clinics providing integrated diagnosis and treatment for airway-related conditions including allergies, asthma, chronic sinusitis, COPD, and sleep disorders. Its core services are organized under a proprietary "One Airway, One Disease" model that consolidates allergy, immunology, pulmonology, ENT, and sleep medicine specialists within a single location alongside in-house diagnostic testing (CT, endoscopy, spirometry, blood and skin allergy tests). Treatment offerings span immunotherapy, sublingual tablets, balloon sinuplasty, Propel sinus implants, CPAP therapy, and ambulatory IV infusion services through its Precision Healthcare division.
Product overview
BreatheAmerica is a healthcare services company operating allergy, asthma, and sinus treatment centers across Louisiana (Shreveport, Bossier City) and New Mexico (Albuquerque, Santa Fe). The company operates under a 'One Airway, One Disease' philosophy, treating the entire airway system holistically rather than isolated symptoms. Its core service portfolio includes: Allergy Treatment (diagnostic testing via skin tests, blood tests, oral challenges; treatment via avoidance education, medications, and immunotherapy); Asthma/COPD Treatment (diagnosis, pulmonary function testing, medications); Sinus/Sinusitis Treatment (CT imaging, balloon sinuplasty, Propel implants); Sleep Medicine (sleep studies, CPAP therapy); and Precision Infusion (ambulatory infusion centers for advanced drug therapy). Supporting services include Clinical Research (patient participation in clinical trials) and an Online Physician Referral system. The company also provides various diagnostic services including CT/CAT scans, nasal endoscopy, and pulmonary function testing. BreatheAmerica accepts patients from multiple states and accepts various insurance plans including BCBS, Medicare, United HealthCare, and Cigna.
Differentiator
Problem solved
Functional benefit
Products and services
- Allergy Treatment Comprehensive allergy diagnostic testing (skin prick, intradermal, patch, ImmunoCap blood, oral challenges) and treatment (avoidance education, medications, immunotherapy shots, and sublingual tablets) for aeroallergens, foods, venoms, drugs, and chemicals. Targets adult and pediatric patients with allergic rhinitis, food allergies, drug allergies, insect allergies, and anaphylaxis.
- Asthma/COPD Treatment Diagnosis and management of asthma (intermittent, mild, moderate, and severe persistent) and COPD, including spirometry, pulmonary function testing, bronchodilators, anti-inflammatory inhalers, oral medications, and Xolair, for patients whose airway disease is related to allergies or asthma.
- Sinus/Sinusitis Treatment Treatment of chronic and acute sinusitis using CT imaging, medications, balloon sinuplasty, and Propel implants, plus nasal polyp treatment, ear infection management related to sinus issues, and structural nasal abnormality care for adult and pediatric patients.
- Sleep Medicine Sleep disorder diagnosis and treatment including sleep studies, CPAP therapy and supplies with home delivery, and care for obstructive sleep apnea, insomnia, restless leg syndrome, and narcolepsy, with emphasis on airway-linked sleep conditions.
- Precision Infusion Ambulatory infusion centers operated by the Precision Healthcare subsidiary provide hospital-quality IV infusion therapy for advanced drug infusion in a comfortable outpatient setting, including specialty pharmacy, home infusion, and a heart failure program delivered at multiple Tennessee, Arkansas, New Mexico, Oklahoma, and Texas locations.
- Clinical Research Clinical trial participation opportunities for patients with asthma, sinusitis, sleep apnea, allergies, COPD, chronic cough, and hereditary angioedema, offering access to investigational therapies.
- Online Physician Referral Digital referral platform (Preferral.com) allowing referring physicians to submit patient referrals to BreatheAmerica online instead of by fax.
- Balloon Sinuplasty Minimally invasive outpatient procedure that opens blocked sinus passages using a small balloon, allowing patients to return to work the same day. Used to treat the cause of restricted airflow in sinus passages and chronic sinusitis symptoms.
- Propel Sinus Implant Treatment Placement of small dissolvable steroid-releasing implants in the sinus cavity during sinus surgery to hold passages open while healing and prevent polyp regrowth and scar tissue; the implant dissolves naturally over approximately 30 days.
- Sublingual Immunotherapy (SLIT) FDA-approved no-shot allergy treatment using daily sublingual tablets for grass pollen and ragweed allergies; can be self-administered at home with a favorable safety profile as an alternative to injection immunotherapy.
- CPAP Therapy Continuous Positive Airway Pressure (CPAP) therapy and supplies for obstructive sleep apnea patients, including daily compliance monitoring and home delivery of replacement masks and supplies.
Quantifiable outcome
- 26.9 million Americans diagnosed with chronic sinusitis are potential candidates for BreatheAmerica's integrated sinus treatment approach.
- +2 more outcomes
Companies that use BreatheAmerica
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles1 record
BreatheAmerica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BreatheAmerica partnerships and signals
Strategic signalScale indicators10 records
Recent moves7 records
Expansion highlights6 records
BreatheAmerica competitors and assessment
Company assessmentDirect peers
- Aspire Allergy & Sinus: Aspire operates a multi-site integrated allergy, asthma, and sinus clinic network across Texas, Florida, Arizona, and Colorado. Directly comparable to BreatheAmerica's 'One Airway' specialty clinic model with similar SLIT, immunotherapy, and sinus procedure offerings.
- AllerVie Health: AllerVie is a PE-backed specialty platform of allergy, asthma, and immunology clinics operating across the Sun Belt. Closely mirrors BreatheAmerica's clinic-based, multi-specialty airway care strategy with in-house diagnostics and immunotherapy.
- Family Allergy & Asthma: Family Allergy & Asthma is a regional network of physician-led allergy and asthma clinics across Kentucky, Indiana, Ohio, and Tennessee. Comparable in specialty focus (allergy/asthma/immunotherapy) and clinic delivery model to BreatheAmerica's Louisiana/New Mexico footprint.
- United Allergy Services: United Allergy Services provides in-clinic allergy testing and immunotherapy services to primary care and specialty practices. Comparable to BreatheAmerica's allergy diagnostic and SLIT/SCIT immunotherapy offerings, with an overlapping B2B healthcare-provider channel.
- ENT and Allergy Associates: ENT and Allergy Associates is a large multi-specialty physician practice combining otolaryngology, allergy, and audiology across the Northeast U.S. Comparable service mix to BreatheAmerica's combined ENT/allergy/pulmonology offering, though much larger scale.
Broad incumbents
- Option Care Health: Option Care Health is the largest U.S. independent provider of home and alternate-site infusion services. Directly comparable to BreatheAmerica's Precision Healthcare/Infusion subsidiary in ambulatory infusion therapy and specialty pharmacy delivery.
- Royal Philips (Sleep & Respiratory Care): Philips' Sleep & Respiratory Care business sells CPAP/BiPAP devices, oxygen therapy, and respiratory care solutions. Comparable to BreatheAmerica's sleep medicine, CPAP therapy, and oxygen/respiratory DME service offerings as a broad incumbent in the airway category.
- ResMed: ResMed is a global leader in sleep-disordered breathing devices (CPAP, BiPAP) and connected health. Comparable to BreatheAmerica's Sleep Medicine service line and CPAP therapy/supplies business through overlapping device-and-supply economics.
- Soleo Health: Soleo Health is a national specialty infusion and home infusion provider focused on complex therapies. Comparable to Precision Healthcare's ambulatory infusion, home infusion, and specialty pharmacy service lines.
- US ENT Partners: US ENT Partners is a management services organization supporting ENT and allergy practices across multiple states. Comparable in specialty focus (ENT, allergy, sinus surgery) and PE-backed roll-up model to BreatheAmerica.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BreatheAmerica social profiles
Digital presenceBreatheAmerica financial estimates
Financial estimateRevenue estimate
Valuation estimate
BreatheAmerica leadership team
Management profileNumber of profiles
Profiles7 records
BreatheAmerica subsidiaries and ownership
Company hierarchySubsidiaries1 record
BreatheAmerica funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BreatheAmerica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BreatheAmerica
What does BreatheAmerica do?
BreatheAmerica operates outpatient specialty clinics providing integrated diagnosis and treatment for airway-related conditions including allergies, asthma, chronic sinusitis, COPD, and sleep disorders. Its core services are organized under a proprietary "One Airway, One Disease" model that consolidates allergy, immunology, pulmonology, ENT, and sleep medicine specialists within a single location alongside in-house diagnostic testing (CT, endoscopy, spirometry, blood and skin allergy tests). Treatment offerings span immunotherapy, sublingual tablets, balloon sinuplasty, Propel sinus implants, CPAP therapy, and ambulatory IV infusion services through its Precision Healthcare division.
Is BreatheAmerica a public or private company?
BreatheAmerica is a private company. It is classified as private equity controlled and is currently operating.
When was BreatheAmerica founded?
BreatheAmerica was founded in 2006. It employs 51 to 100 people.
Where is BreatheAmerica based?
BreatheAmerica is headquartered in Nashville, United States, in the North America region.
How does BreatheAmerica make money?
Two revenue lines are on record. Clinical Healthcare Services are the primary driver. The others are precision Infusion Services.
Who are BreatheAmerica's main competitors?
Direct peers on record are Aspire Allergy & Sinus, AllerVie Health, Family Allergy & Asthma, United Allergy Services and ENT and Allergy Associates. Broad incumbents are Option Care Health, Royal Philips (Sleep & Respiratory Care), ResMed, Soleo Health and US ENT Partners.
Does BreatheAmerica have an API?
No public API is recorded for BreatheAmerica.